Space Exploration Technologies (SPCX) has filed a US$3.42 billion shelf registration for Class A common stock, allowing it to issue 23.6 million shares as funding needs arise. The shares rose 26.2% over 90 days, helped by Q3 profitability, a US$40 billion AI chip financing and ongoing Tesla merger discussions, but are down 8.7% year to date at a last close of US$146.90. The recent pullback suggests investors are weighing dilution risk and higher leverage against the growth story. The most-followed narrative puts fair value at just $0.46 per share, while Simply Wall St's DCF model estimates $420.37 per share, with SPCX trading 65.1% below that value.
Summary written by Upside AI from the original article. Read the source for full details.
Read the original on Yahoo Finance ↗
Keywords
Open a keyword to see other news on the same topic.
Related tickers and likely impact
TSLA
• NeutralTesla, Inc.
Relevance: low
| Market | US stocks |
|---|---|
| Sector | Consumer Discretionary |
| Industry | Automobile Manufacturers |
| Market cap | $1.5T |
| Close on 10/27/2026 | 407.46 |
| Change that session | +4.04% |
Impact is scored by AI from the headline and may be wrong. It is not investment advice.
Related news
- Here's What $10,000 Invested in SpaceX and Tesla Could Be Worth in 2030
The article models a $10,000 split between 14 Tesla shares and 34 SpaceX shares, assuming SpaceX acquires Tesla in an all-stock deal at a 30% premium with 3.16 SpaceX shares per Tesla share, leaving investors with about 68 SpaceX shares. Using 2031 revenue consensus of $331 billion for Tesla and $830.8 billion for SpaceX, a 10x forward price-to-sales multiple implies a combined value of $11.6 trillion, or about $452 per share in 2030 and over $30,700 for 68 shares. The author calls this a 3x-plus return over several years, but notes that the merger may not happen and revenue may fall short. Prediction market Kalshi puts the odds of a merger at 57% before April 2027 and 77% before the end of 2028, and Barclays analyst Dan Levy thinks an announcement could come before Tesla's December 6, 2026 annual meeting.
- Tesla Stock vs. the S&P 500: Which Investment Wins Through 2030?
The article argues Tesla trades at roughly 203 times this year's expected earnings and 13 times expected sales, a valuation that looks very expensive given gross margin pressure and a slower-than-expected robotaxi rollout. The flying Roadster, slated for production in 2028, is unlikely to make a meaningful sales or earnings contribution before 2030. The author thinks a Tesla-SpaceX merger by the end of the decade, likely an all-stock deal, is more likely than not and would be a key factor in how Tesla stock performs against the S&P 500 through 2030.
- Which AI stocks' valuations are outrunning reality?
The Market Hang panel of four guests discusses which AI stocks have reasonable valuations and which are being hyped on speculation. They argue Tesla and SpaceX have no valuation basis and should not be grouped with other companies, while most large names such as Oracle and Apple are seen within a reasonable range, though Apple is at the high end at roughly 35–40 times earnings. AMD is considered expensive, while Google, at about 24 times earnings, is judged not unreasonable given its large cash flow and internal ecosystem. One guest also warned about nuclear companies that have no profits and depend on government reimbursement.
- Why Is SpaceX Stock Surging in Pre-Market Trading?
SpaceX (NASDAQ:SPCX) was reported to have risen nearly 10% in pre-market trading on Wednesday after third-quarter results beat expectations and reports emerged of possible merger talks with Tesla. Revenue reached $14.58 billion, up 161% year on year and above the $12.74 billion consensus, with EPS of $0.35 versus $0.12 expected, its first quarterly profit since listing. The Super Intelligence division generated $7.6 billion, up 830%, and surpassed Starlink's revenue for the first time, while Starlink reported $5.2 billion, up 69%, and 13.6 million subscribers. Musk said on the earnings call that independent special committees at SpaceX and Tesla are evaluating a merger, though no definitive agreement has been reached. Citigroup raised its price target from $200 to $240.
- Elon Musk Says He Will Give One SPCX Share To Every US Child Next Year – ‘Will Be First Of Many’
SpaceX (SPCX) and Tesla (TSLA) CEO Elon Musk said he plans to give one SPCX share to every U.S. child next year, calling it “the first of many.” With around 70 million Americans under 18 and SPCX closing near $146 on Friday, the gift would be worth about $10.2 billion, a little more than 1% of the six-plus billion SpaceX shares Musk controls. Implementation details remain unclear, including eligibility, which share class would be used, how shares would be transferred to minors, and tax treatment; the plan could be tied to Trump Accounts, which SpaceX President Gwynne Shotwell and her husband supported in July for more than two million children, valued at about $325 million at the time. SpaceX is scheduled to report earnings after the bell on Tuesday, with analysts expecting EPS of $0.13 on revenue of $13.02 billion.
- Meta, Tesla, SpaceX Take Center Stage As Earnings Season Kicks Into High Gear. Everything You Need To Know.
Related markets
Latest news
- Investing $1,000 in Each of These 3 Stocks 20 Years Ago Would Have Created a Portfolio Worth $674,000 Today
The article calculates that a $1,000 investment in each of Nvidia, Netflix and Amazon 20 years ago would be worth about $674,000 combined as of October 26. Nvidia's stake would be worth about $383,000, with most gains coming in the past couple of years as generative AI took off; the chipmaker's operating profit totaled nearly $200 billion over the past four quarters, its market cap is around $5.3 trillion, and it trades at 28 times trailing earnings. Netflix's stake would be worth more than $161,000, but its stock has fallen this year on concerns about slowing growth and is trading near its 52-week low. Amazon's stake would be worth about $130,000, and its operating income last year reached $80 billion, more than six times the $12 billion of three years earlier; the stock trades at around 20 times trailing earnings. The author argues these growth stocks can still be good buys today.
- Western Digital, Allegro MicroSystems, Amtech, and Teradyne shares skyrocket, what you need to know
Several semiconductor stocks rose sharply in the afternoon session after Broadcom obtained $63 billion in bank financing to develop proprietary AI chips for Anthropic. Alongside Anthropic's IPO filing and Meta's equity offering, the news signaled that tech capital spending remains robust. Among the gainers, Western Digital (WDC) rose 8.1%, Allegro MicroSystems (ALGM) gained 6.4%, Amtech (ASYS) added 5.1% and Teradyne (TER) climbed 5.6%. The article notes WDC has had 79 moves greater than 5% over the past year, and about 22 hours earlier the stock had gained 5.2% after Bank of America projected memory chip supplies would stay tight through 2028. Citing CNBC, the article says semiconductor fabrication equipment spending is projected to exceed $200 billion in 2027, as demand outpaces clean-room capacity and the availability of critical parts.
- Why Cerebras Systems Stock Jumped on Tuesday
Cerebras Systems (CBRS) shares rose sharply on Tuesday, climbing as much as 11.2% intraday and closing up 10.1%, after the company announced its fast inference service would be available to Oracle Cloud Infrastructure (OCI) customers. Cerebras says its Wafer-Scale Engine packs 900,000 compute cores and is 58 times larger than Nvidia's Blackwell B200 chip, and that integrating compute and memory on one wafer reduces latency, a key issue for AI agent workflows. In the second quarter, its cloud revenue surged 287% to a record $128 million and total revenue rose 103% to $210 million, though losses continue to mount as it expands data center capacity. The article notes the technology is still finding its customer base and that Cerebras competes directly with Nvidia. At 39 times sales, the article says its valuation reflects considerable growth expectations.
- Billionaire Stanley Druckenmiller Added to Revolution Medicines Before Its FDA Win. Is the Stock Still a Buy After a 134% Run?
Duquesne Family Office, led by billionaire Stanley Druckenmiller, increased its Revolution Medicines stake by 26.5% in the second quarter, before the company's Rasonque won U.S. approval in August for certain pancreatic cancer patients. In a Phase 3 study, Rasonque achieved median overall survival of 13.2 months versus 6.7 months for chemotherapy, and some estimates project it could generate $15.1 billion in revenue by 2034 from pancreatic cancer alone. Some estimates put the number of U.S. patients diagnosed annually with metastatic pancreatic cancer at 55,000, with about 19,000 moving on to second-line treatment; assuming a roughly 30% net discount, the opportunity is nearly $3 billion a year. With a market cap of about $40 billion that has fallen since approval, the author says that at a 12% required rate of return and a forward price-to-sales ratio of 4 by 2031, revenue would need to reach $17.62 billion in 2032 to justify the current valuation. The author says they would seriously consider investing if the market cap falls by another $5 billion, citing clinical, regulatory and biotech volatility risks.
- Why Tech Giants Keep Laying Off Staff
On October 26, Microsoft said it is offering about 60,000 employees voluntary departure packages with severance, equal to more than 25% of its global workforce, as it seeks to cut costs and redirect funds to AI investment. Other companies have made big cuts this year, including Meta's 10% reduction (about 8,000 people) and Block's 40% cut (over 4,000 employees), and Layoffs.fyi counts more than 135,000 tech job cuts so far. The article says companies are prioritizing spending on AI chips and data centers and believe they can operate with fewer staff, although some reductions mainly correct earlier over-hiring. However, analysts warn that mass layoffs can hurt morale and push talented workers to leave, while humans are still needed to design business models, serve customers and ensure AI tools are used safely. The layoffs also reinforce fears that AI will destroy jobs, which could fuel opposition to data centers and the technology itself.
- JPM's Agather & Herbst on Texas Wealth Wave
Elaine Agather, Global Vice Chair of J.P. Morgan Private Bank and Dallas Region Chairman of JPMorgan Chase, and Ashley Herbst, Managing Director and Head of Dallas for J.P. Morgan Private Bank, speak with Bloomberg's Joe Lovinger about capital inflows, generational wealth transfer and Texas' changing investment landscape. The discussion takes place at Bloomberg Invest Dallas 2026.
Get the briefing on Telegram or Zalo
Join the Upside Telegram channel or Zalo group for the Vietnam stocks and gold briefing at 8:00 and 19:00 (Vietnam time) on trading days, plus a weekly wrap on Saturday morning.